Search for: "Amgen Inc" Results 41 - 60 of 698
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Federal Circuit Nixes APA Challenge to PTAB Pilot, Cites Amgen in Enablement Analysis
28 Jun 2023, 4:15 am by Steve Brachmann
Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision in Medytox, Inc. v. [read post]
IPWatchdog.com | Patent Copyright Trademark - http://www.ipwatchdog.com
In re Couvaras (Fed. Cir. 2023)
27 Jun 2023, 7:32 pm by Patent Docs
Cir. 2023)Amgen Inc. v. [read post]
Patent Docs - http://www.patentdocs.org/
FTC v Amgen: The Economics of Bundled Discounts, Part Two
9 Jun 2023, 8:36 am by Ashwin Varma
The Federal Trade Commission (FTC) recently announced that it would sue to block Amgen’s proposed $27.8 billion acquisition of Horizon Therapeutics. [read post]
Truth on the Market - http://truthonthemarket.com/
FTC v Amgen: The Economics of Bundled Discounts, Part Two
9 Jun 2023, 8:36 am by Ashwin Varma
The Federal Trade Commission (FTC) recently announced that it would sue to block Amgen’s proposed $27.8 billion acquisition of Horizon Therapeutics. [read post]
Truth on the Market - http://truthonthemarket.com/
Jack Daniels wins big in challenge to spoofing “Bad Spaniels” dog toy
9 Jun 2023, 8:20 am by Ronald Mann
Goldsmith for copyrights and Amgen Inc. v. [read post]
SCOTUSblog - http://www.scotusblog.com/
US Supreme Court decision in Amgen v Sanofi: The European Perspective
31 May 2023, 9:43 am by Rose Hughes
Cir. 2021), the Supreme Court found Amgen's function and epitope defined PCSK9 antibody patents to lack enablement (Amgen Inc v Sanofi, No. 21-757). [read post]
IPKat - http://ipkitten.blogspot.com/
The Antitrust Week In Review
26 May 2023, 9:08 am by Zak Gowen
Federal Trade Commission has filed a lawsuit to stop Amgen Inc’s $27.8 billion acquisition of Horizon Therapeutics Plc in a rare move to block a large pharmaceutical deal. [read post]
Antitrust Today - https://constantinecannon.com/practice/antitrust-litigation-counseling/antitrust-today/
SCOTUS: “The More a Party Claims for Itself the More it Must Enable”
22 May 2023, 4:59 pm by Nathan Lee and Daniel Yannuzzi
On May 18, 2023, the Supreme Court of the United States issued a unanimous decision in the case of Amgen Inc. et al. v. [read post]
Intellectual Property Law Blog - http://www.intellectualpropertylawblog.com/
Dear Stephen Breyer
19 May 2023, 4:03 pm by Mark Walsh
The justices ruled in favor of social media companies in Twitter, Inc. v. [read post]
SCOTUSblog - http://www.scotusblog.com/
Supreme Court rules invalid Amgen’s patent on cholesterol-lowering drug
19 May 2023, 9:45 am by Eric M. Fraser
Justice Neil Gorsuch wrote for a unanimous court in Amgen Inc. v. [read post]
SCOTUSblog - http://www.scotusblog.com/
The Internet Survives SCOTUS Review (This Time)–Twitter v. Taamneh and Gonzalez v. Google
18 May 2023, 1:21 pm by Eric Goldman
Twitter, Inc. v. [read post]
Technology & Marketing Law Blog - http://blog.ericgoldman.org/
SCOTUS Ushers in New Era of Enablement Law in Amgen Ruling
18 May 2023, 12:15 pm by Gene Quinn
Earlier today, the United States Supreme Court issued its decision in Amgen, Inc. v. [read post]
IPWatchdog.com | Patent Copyright Trademark - http://www.ipwatchdog.com
SCOTUS Ushers in New Era of Enablement Law in Amgen Ruling
18 May 2023, 12:15 pm by Gene Quinn
Earlier today, the United States Supreme Court issued its decision in Amgen, Inc. v. [read post]
IPWatchdog - http://www.ipwatchdog.com/
Shaping the Future of Patent Law: The Amgen v. Sanofi Decision and Bite-Sized Monopolies
18 May 2023, 8:20 am by Dennis Crouch
The case in question is Amgen Inc. v. [read post]
Patently-O - https://patentlyo.com
Announcement of opinions for Thursday, May 18 (complete)
17 May 2023, 9:00 pm by SCOTUSblog
ShareOn Thursday, May 18, we live blogged as the court issued opinions in Amgen Inc. v. [read post]
SCOTUSblog - http://www.scotusblog.com/
Amgen v. Sanofi and Regeneron: Japan IP High Court overrules its own decision on validity of Amgen patent
15 May 2023, 1:47 am by Mami Hino (Abe, Ikubo & Katayama) and Naho Ebata (Abe, Ikubo & Katayama)
On January 26, 2023, Regeneron Pharmaceuticals, Inc., who sought to invalidate Amgen Inc. [read post]
Kluwer Patent Blog - http://patentblog.kluweriplaw.com/
Supreme Court Holds Over Two Patent Cases, Considers Two More on Patent Eligibility
1 May 2023, 10:11 am by Dennis Crouch
Teva Pharmaceuticals USA, Inc. v. [read post]
Patently-O - https://patentlyo.com
Functional Claims: Morse, Halliburton & Amgen
27 Apr 2023, 11:51 am by Dennis Crouch
The pending Supreme Court case of Amgen Inc. v. [read post]
Patently-O - https://patentlyo.com
Amgen Scores Partial Victory in Efforts to Maintain OTEZLA Exclusivity
21 Apr 2023, 9:27 am by Holman
By Chris Holman Amgen Inc. v. [read post]
Patently-O - https://patentlyo.com
Obviousness and Stereochemistry
21 Apr 2023, 7:07 am by Jordan Duenckel
Amgen Inc., v. [read post]
Patently-O - https://patentlyo.com